Table 2.
Distribution of opportunistic disease and CD4 T cell count
| Variable | No. of cases | CD4 T cell, cell/mm3 |
|---|---|---|
| Candidiasis | 176 (16.2) | |
| Oral candidiasis | 120 | 49 (17–133) |
| Esophageal candidiasis | 54 | 43 (19–95.5) |
| Respiratory candidiasis | 2 | - |
| Tuberculosis | 120 (11.0) | 87 (37–205) |
| Nontuberculous Mycobacteria infection | 2 (0.2) | - |
| Pneumocystis jirovecii pneumonia | 121 (11.1) | 30 (11–68) |
| CMV infection | 52 (4.7) | 25.5 (12.75–101.5) |
| Retinitis | 19 | |
| Pneumonia | 13 | |
| Hepatitis | 9 | |
| Colitis | 2 | |
| Cytomegalovirus viremia | 9 | |
| Herpes zoster | 44 (4.0) | 185 (116.5–273.5) |
| Herpes simplex virus infection | 8 (0.7) | 128 (10–320) |
| Recurrent pneumonia | 7 (0.7) | 62.5 (12–170) |
| Progressive multifocal leukoencephalopathy | 6 (0.6) | 107 (64.25–154) |
| Cryptococcosis | 6 (0.6) | 31.2 (9.5–76.75) |
| Toxoplasmosis | 4 (0.4) | 107 (25.5–246.25) |
| Isosporiasis | 1 (0.09) | - |
| Non-Hodgkin’s lymphoma | 4 (0.4) | 128 (26–222.5) |
| Burkitt lymphoma | 1 | |
| Diffuse large B-cell lymphoma | 3 | |
| Kaposi’s sarcoma | 8 (0.7) | 133 (28–269) |
| Cervical carcinoma | 1 (0.09) | - |
Values are presented as number (%) or median (interquartile range).